SCHEMBL2315

SCHEMBL2315

[CH]1CC[CH]CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9867340 1.00
SCHEMBL11616911 0.94
SCHEMBL93121 0.94
SCHEMBL93167 0.89
SCHEMBL64999 0.89
SCHEMBL4357767 0.84
SCHEMBL4355358 0.84
SCHEMBL4361911 0.84
SCHEMBL7495989 0.84
SCHEMBL4361508 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1490 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240190883-A1 KRAS PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS BIOTHERYX, INC. (US) 2024-06-13 US claimed
US-20240174643-A1 SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS BIOTHERYX, INC. (US) 2024-05-30 US claimed
EP-4355741-A1 SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS Biotheryx, Inc. (US) 2024-04-24 EP claimed
EP-4333852-A1 LARGE-CONDUCTANCE POTASSIUM CHANNEL MODULATORS, COMPOSITIONS THEREOF, METHODS OF MANUFACTURING THEREOF, AND METHODS OF USE THEREOF Enalare Therapeutics Inc. (US) 2024-03-13 EP claimed
CN-112745861-B Liquid crystal composition, optical element and liquid crystal display element 捷恩智株式会社 2023-11-21 CN claimed
WO-2023220640-A1 CDK PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS BIOTHERYX, INC. (US) 2023-11-16 WO claimed
CN-111201220-B Polymerizable liquid crystal compound, polymerizable composition, retardation film, transfer laminate, and optical member 大日本印刷株式会社 2023-10-17 CN claimed
WO-2023178130-A1 SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS BIOTHERYX, INC. (US) 2023-09-21 WO claimed
CN-112334441-B Polymerizable polar compound, liquid crystal composition, and liquid crystal display element 捷恩智株式会社 2023-08-01 CN claimed
WO-2023023531-A1 ESTROGEN RECEPTOR DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS BIOTHERYX, INC. (US) 2023-02-23 WO claimed
US-6746731-B1 ACHIEVES VERY HIGH MAXIMUM TRANSMISSION AND VERY HIGH CONTRAST AND CONSTANT THRESHOLD VOLTAGE OVER BROAD TEMPERATURE RANGE CLARIANT GMBH (DE) 2004-06-08 US claimed
JP-2002532613-A 2002-10-02 JP claimed
EP-0898558-B1 PROCESS FOR THE CARBONYLATION OF ETHYLENICALLY UNSATURATED COMPOUNDS SHELL INTERNATIONALE RES BR MI (NL) 2001-11-07 EP claimed
EP-1147162-A1 FERROELECTRIC ACTIVE MATRIX DISPLAYS WITH WIDE OPERATING TEMPERATURE RANGE Clariant GmbH (DE) 2001-10-24 EP claimed
US-6103927-A BY REACTION THEREOF WITH CARBON MONOXIDE AND A COREACTANT IN THE PRESENCE OF HALIDE ANIONS AND CATALYST SYSTEM COMPRISING GROUP VIII METAL CATION; PHOSPHINE, ARSINE, OR STILBINE LIGAND; AND A SOURCE OF ANIONS, OTHER THAN HALIDE; PROVIDES SHELL OIL COMPANY (US) 2000-08-15 US claimed
JP-2000508652-A 2000-07-11 JP claimed
WO-2000036054-A1 FERROELECTRIC ACTIVE MATRIX DISPLAYS WITH WIDE OPERATING TEMPERATURE RANGE CLARIANT GMBH (DE) 2000-06-22 WO claimed
EP-0898558-A1 PROCESS FOR THE CARBONYLATION OF ETHYLENICALLY UNSATURATED COMPOUNDS SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1999-03-03 EP claimed
US-5780684-A CATALYSTS SHELL OIL COMPANY (US) 1998-07-14 US claimed
WO-1997038964-A1 PROCESS FOR THE CARBONYLATION OF ETHYLENICALLY UNSATURATED COMPOUNDS SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 1997-10-23 WO claimed